» Articles » PMID: 31320775

Facilitators and Barriers to Antibiotic Stewardship: A Qualitative Study of Pharmacists' Perspectives

Overview
Journal Hosp Pharm
Publisher Sage Publications
Date 2019 Jul 20
PMID 31320775
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The Veterans Affairs (VA) is a leader in the implementation and advancement of antibiotic stewardship programs throughout the nation. The Centers for Disease Control and Prevention (CDC) has also led national antibiotic stewardship efforts and has outlined core elements to improve antibiotic use in hospitals, long-term care, and outpatient settings. Many facilities still face challenges to the implementation and maintenance of successful programs, particularly in nonacute care settings. The objective of this study was to identify barriers and facilitators to antibiotic stewardship within the VA medical centers through qualitative interviews with pharmacists. Eight semi-structured telephone interviews were conducted with pharmacists from 6 VA medical centers within VA New England Healthcare System. Pharmacist respondents were either pharmacy champions (for medical centers with established programs) or pharmacists with responsibilities in making antibiotic recommendations (locations without established programs). All interviews were audio recorded and transcribed verbatim. NVivo 8 was used for data coding and analysis. Pharmacists from all 8 medical centers were contacted for interviews and pharmacists from 6 medical centers agreed to interviews (75% VA New England medical center participation). Three main themes regarding antibiotic stewardship were identified from the interviews with pharmacists. Respondents described the importance of (1) a supportive organizational culture, (2) protected time for antibiotic stewardship, and (3) a cohesive organizational structure in the success of antibiotic stewardship programs. Our findings support the CDC core elements for antibiotic stewardship, in particular the importance of leadership commitment in the creation of a culture that supports antibiotic stewardship and in ensuring staff are given sufficient time for antibiotic stewardship efforts. Although a strong supportive culture has been built, strategies focused on fostering increased protected time for antibiotic stewardship and a cohesive organizational structure may be helpful in advancing and sustaining successful antibiotic stewardship programs that improve patient outcomes.

Citing Articles

Pharmacist roles in antimicrobial stewardship: a qualitative study from India, South Africa and the United Kingdom.

Nampoothiri V, Mbamalu O, Mendelson M, Singh S, Charani E JAC Antimicrob Resist. 2024; 6(3):dlae047.

PMID: 38716399 PMC: 11073750. DOI: 10.1093/jacamr/dlae047.


Implementation of antimicrobial stewardship programs: A study of prescribers' perspective of facilitators and barriers.

Chukwu E, Abuh D, Idigbe I, Osuolale K, Chuka-Ebene V, Awoderu O PLoS One. 2024; 19(1):e0297472.

PMID: 38241406 PMC: 10798493. DOI: 10.1371/journal.pone.0297472.


A qualitative evaluation of frontline clinician perspectives toward antibiotic stewardship programs.

Tjilos M, Drainoni M, Burrowes S, Butler J, Damschroder L, Goetz M Infect Control Hosp Epidemiol. 2023; 44(12):1995-2001.

PMID: 36987859 PMC: 10755145. DOI: 10.1017/ice.2023.35.


Facilitators and barriers to implementing antimicrobial stewardship programs in public South African hospitals.

Scheepers L, Niesing C, Bester P Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e34.

PMID: 36865702 PMC: 9972532. DOI: 10.1017/ash.2022.355.


Current Status of Antibiotic Stewardship and the Role of Biomarkers in Antibiotic Stewardship Programs.

Kim C Infect Chemother. 2023; 54(4):674-698.

PMID: 36596680 PMC: 9840952. DOI: 10.3947/ic.2022.0172.


References
1.
Lautenbach E, Weiner M, Nachamkin I, Bilker W, Sheridan A, Fishman N . Imipenem resistance among pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2006; 27(9):893-900. DOI: 10.1086/507274. View

2.
Dellit T, Owens R, McGowan Jr J, Gerding D, Weinstein R, Burke J . Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2006; 44(2):159-77. DOI: 10.1086/510393. View

3.
Ploeg J, Davies B, Edwards N, Gifford W, Miller P . Factors influencing best-practice guideline implementation: lessons learned from administrators, nursing staff, and project leaders. Worldviews Evid Based Nurs. 2007; 4(4):210-9. DOI: 10.1111/j.1741-6787.2007.00106.x. View

4.
Patel G, Huprikar S, Factor S, Jenkins S, Calfee D . Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008; 29(12):1099-106. DOI: 10.1086/592412. View

5.
Roberts R, Hota B, Ahmad I, Scott 2nd R, Foster S, Abbasi F . Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis. 2009; 49(8):1175-84. DOI: 10.1086/605630. View